Imunon, Inc. (IMNN:NASDAQ) closed at $1.19 on October 21, 2026, up 18.41% on the day. The stock trades 76.7% below its 52-week high of $5.10 and 24.0% above its 52-week low of $0.960. Over the past year, it lost 74.7%. Imunon, Inc. is part of the Health Care sector.
In 252 trading sessions since October 21, 2025, IMNN closed higher on 89 days (35%). Its best day was October 21, 2026 (+18.41%) and its worst was November 4, 2025 (-12.07%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 2 times.
Celsion Corp is active in the biotechnology sector. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in a clinical trial for the treatment of primary liver cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.
Find more stocks like IMNN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.